Tech Company Financing Transactions

PathAI Funding Round

On 11/5/2019, PathAI raised $75 million in Series B funding from General Atlantic, Bristol-Myers Squibb and General Catalyst Partners.

Transaction Overview

Company Name
PathAI
Announced On
11/5/2019
Transaction Type
Venture Equity
Amount
$75,000,000
Round
Series B
Investors

General Atlantic (Lead Investor) (Michelle Dipp)

Bristol-Myers Squibb

General Catalyst Partners (David Fialkow)

LabCorp

Merck Global Health Innovation Fund

Proceeds Purpose
PathAI will use the funding to bolster and accelerate its growing clinical development capabilities.

Company Information

Company Status
Private & Independent
Industry
Artificial Intelligence
Mailing Address
1325 Boylston St. 10000
Boston, MA 02215
USA
Phone
Undisclosed
Website
www.pathai.com
Email Address
[email protected]
Overview
PathAI's mission is to advance medicine with intelligent pathology. PathAI's platform provides end-to-end data-driven pathology analysis, resulting in fast, accurate and standardized pathologic diagnoses.
Profile
PathAI LinkedIn Company Profile
Social Media
PathAI Company Twitter Account
Company News
PathAI News
Facebook
PathAI on Facebook
YouTube
PathAI on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Andrew Beck
  Andrew Beck LinkedIn Profile  Andrew Beck Twitter Account  Andrew Beck News  Andrew Beck on Facebook
Chief Information Officer
Joe Adu
  Joe Adu LinkedIn Profile  Joe Adu Twitter Account  Joe Adu News  Joe Adu on Facebook
Chief Scientific Officer
Michael Montalto
  Michael Montalto LinkedIn Profile  Michael Montalto Twitter Account  Michael Montalto News  Michael Montalto on Facebook
Chief Technical Officer
Aditya Khosla
  Aditya Khosla LinkedIn Profile  Aditya Khosla Twitter Account  Aditya Khosla News  Aditya Khosla on Facebook
Vice President
Nick Brown
  Nick Brown LinkedIn Profile  Nick Brown Twitter Account  Nick Brown News  Nick Brown on Facebook
Vice President
Deirdre DeSteno
  Deirdre DeSteno LinkedIn Profile  Deirdre DeSteno Twitter Account  Deirdre DeSteno News  Deirdre DeSteno on Facebook
Vice President
Murtaza Mehdi
  Murtaza Mehdi LinkedIn Profile  Murtaza Mehdi Twitter Account  Murtaza Mehdi News  Murtaza Mehdi on Facebook
Vice President
Murray Resnick
  Murray Resnick LinkedIn Profile  Murray Resnick Twitter Account  Murray Resnick News  Murray Resnick on Facebook
Vice President
Nathan Silberman
  Nathan Silberman LinkedIn Profile  Nathan Silberman Twitter Account  Nathan Silberman News  Nathan Silberman on Facebook
Vice President
Ilan Wapinski
  Ilan Wapinski LinkedIn Profile  Ilan Wapinski Twitter Account  Ilan Wapinski News  Ilan Wapinski on Facebook
VP - Bus. Development
Tiffany Freitas
  Tiffany Freitas LinkedIn Profile  Tiffany Freitas Twitter Account  Tiffany Freitas News  Tiffany Freitas on Facebook
VP - Engineering
Peter Lazzarino
  Peter Lazzarino LinkedIn Profile  Peter Lazzarino Twitter Account  Peter Lazzarino News  Peter Lazzarino on Facebook
VP - Engineering
Donald O'Neill
  Donald O'Neill LinkedIn Profile  Donald O'Neill Twitter Account  Donald O'Neill News  Donald O'Neill on Facebook
VP - Human Resources
Andrew Moffit
  Andrew Moffit LinkedIn Profile  Andrew Moffit Twitter Account  Andrew Moffit News  Andrew Moffit on Facebook
VP - Operations
Elizabeth Storti
  Elizabeth Storti LinkedIn Profile  Elizabeth Storti Twitter Account  Elizabeth Storti News  Elizabeth Storti on Facebook
VP - Product Management
Megan Rothney
  Megan Rothney LinkedIn Profile  Megan Rothney Twitter Account  Megan Rothney News  Megan Rothney on Facebook
VP - Product Management
Bik Yonjan
  Bik Yonjan LinkedIn Profile  Bik Yonjan Twitter Account  Bik Yonjan News  Bik Yonjan on Facebook
VP - Regulatory Affairs
Lety Booth
  Lety Booth LinkedIn Profile  Lety Booth Twitter Account  Lety Booth News  Lety Booth on Facebook
VP - Regulatory Affairs
Katy Wack
  Katy Wack LinkedIn Profile  Katy Wack Twitter Account  Katy Wack News  Katy Wack on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/5/2019: Leafly venture capital transaction
Next: 11/5/2019: Healthify venture capital transaction

 

Share this article

 

Where The Data Comes From

We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.